Among many mechanisms of immune evasion by tumors, loss of HLA proteins may serve as one way in which aberrant cells “hide” from immune surveillance. While these events may be rarely seen by any individual HLA laboratory, they can and do happen. In this webinar, we’ll examine a real example of HLA mutation in a bone marrow transplant case from my laboratory. Then we’ll delve into the current literature related to somatic mutations in HLA genes to put this case in context
Attend the webinar and receive 0.15 continuing education credits (CECs).
